Double-spun plasma with matched FFPE tissue
Connect circulating biomarker research with matched tumor tissue. Explore paired double-spun plasma and FFPE collections across cancer indications, with additional tissue characterization available for your study.
Plasma and tissue from the same donor
Bring blood-based biomarker research into the context of the matched surgical specimen.
Matched plasma and FFPE tissue
Pair double-spun plasma with archived FFPE tissue to investigate circulating biomarkers alongside findings in the tumor. Selected collections also include matched whole blood; the available material is confirmed for each study.
Double centrifugation reduces residual cells and debris that can interfere with cell-free DNA (cfDNA) analysis.
- Paired materials
- FFPE tissue with double-spun plasma or whole blood
- Collection source
- Ukraine, for the paired collection featured below
- Clinical context
- This paired collection does not include outcome data.
- Study planning
- Available donors, volumes and specimen documentation are reviewed against your requirements.
Explore paired collections by cancer type
The featured collection brings together FFPE tissue and matched plasma or whole blood across eight cancer indications.
Cancer types represented
Define the donor count, specimen format and blood-based material your project needs.
- Non-small-cell lung cancer (NSCLC)
- Colorectal cancer
- Gastric adenocarcinoma
- Renal cell carcinoma
- Esophageal cancer
- Endometrial cancer
- Ovarian cancer
- Melanoma
Contact us for current sample availability and plasma volumes.
For breast cancer or other plasma requests, contact us to discuss the available collection options. The broader FFPE catalogue includes additional tissue cohorts; matched plasma availability is reviewed separately.
Explore FFPE cohortsFFPE cohorts with matched plasma
Explore 11 FFPE cohorts with matched plasma for tissue and blood-based research. Plasma preparation varies by cohort; contact our team to discuss processing and sample requirements.
- Cohort #187 — Bladder cancer (UC) with matched double spun plasma
- Cohort #180 — Breast cancer with matched double spun plasma
- Cohort #179 — CRC with matched double spun plasma
- Cohort #68 — Endometrial cancer with histopath data & matched double-spun plasma
- Cohort #181 — Gastric ADC with matched double spun plasma
- Cohort #183 — Head & Neck SCC with matched double spun plasma
- Cohort #182 — RCC with matched double spun plasma
- Cohort #138 — NSCLC with histopath data & matched plasma
- Cohort #184 — Ovarian cancer with matched double spun plasma
- Cohort #186 — Pancreatic ADC with matched double spun plasma
- Cohort #185 — Prostate ADC with matched double spun plasma
Assays & pathology support
Characterize the matched tissue
Connect your plasma study with protein and RNA measurements in the matched FFPE tissue.
Protein expression
IHC assay services
Add protein-expression measurements with 100+ optimized IHC assays, or discuss assay development for a new target.
Explore IHC servicesSpatial RNA expression
RNAscope RNA-ISH
Localize target RNA in FFPE tissue, with pre-qualified samples, assay controls and pathologist scoring.
Explore RNAscopeMultiplex protein imaging
Multiplex immunofluorescence
Study protein co-expression, cell phenotypes and spatial relationships in selected FFPE tissue and TMAs.
100+ optimized IHC assays
Selected targets from the IHC library. Multiplex panels are reviewed separately.
Browse the IHC target library →IHC staining on Ventana and Dako platforms. Review and scoring by medical pathologists with pharmaceutical industry experience.
Work with our experienced scientific team to tailor biospecimens, data, and integrated services to your research needs.
Our approach begins with our customers’ science.
We focus our acquisition on patient cohorts that meet the needs of biopharma, clinical, and translational researchers.
Plan your study
Tell us the plasma cohort your study needs
Share your indication, number of donors, plasma volume, matched tissue format and intended analysis. We’ll review the available specimens, accompanying data and any additional tissue characterization.